OR

Ortivus ABSTO Ortivus Stock Report

Last reporting period 31 Dec, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.006

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

ORTI B.ST Stock Analysis

OR

Uncovered

Ortivus AB is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-34/100

Low score

Market cap $B

0.006

Dividend yield

Shares outstanding

44.31 B

Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

View Section: Eyestock Rating